Anions are the negative components of most chemical structures and play many important physiological and pharmacological roles that are of interest to the anaesthetist. Their relevance is reviewed with a particular emphasis on the inorganic anions (halides, bicarbonate, phosphate and sulphate) and the significance and limitations of the anion gap. Organic anions (albumin, lactate) are also discussed, albeit briefly. The suitability of anions for their role in neurotransmission and acid2base balance is outlined.
Anions have many important physiological and pharmacological functions and have, to a large extent, been ignored in anaesthetic textbooks. They are invariably linked to cations but can have pronounced effects in their own right. Although their concentrations are measured in the extracellular fluid compartment in clinical practice, the ion shifts that occur across the cell membrane are not only involved in acid2base and electrolyte balance, but may also form the basis of the molecular mechanisms of anaesthesia.
Inorganic anions

Halogens
Halogenation of hydrocarbons and ethers decreases flammability and increases anaesthetic potency. It also increases cardiac sensitisation to catecholamines in the order: F 2 . C1 2 . Br 2 . I 2 . Fluorination increases the stability of adjacent halogen2carbon bonds but may also increase convulsant properties, especially if the compound has four or more carbon atoms or contains other halogens.
Chloride
Chloride is the main anionic constituent of extracellular fluid (ECF) contributing < 100 mosm.l 21 to its tonicity, and is normally present in the body, unlike the other halogens. Because it is exchangeable with bicarbonate, it has a role in maintaining a normal acid2base state, normal renal tubular function and in the formation of gastric acid. It has been the subject of review in the context of critical care medicine [1] and has important implications for the anaesthetist in the areas of fluid resuscitation and acid2base balance.
Chloride intake
The daily requirement of 1±3 mmol.kg 21 is absorbed from the upper part of the small intestine by the Na
2 co-transport mechanism. The active absorption of sodium and potassium creates an electronegative gradient in the chyme along which chloride ions move. However, in the ileum and large bowel, the enterocytes have an anti-transport mechanism that exchanges chloride ions for bicarbonate. The physiological significance of the latter is uncertain but impairment of this transport mechanism leads to congenital chloride diarrhoea, an autosomal recessive disorder.
Chloride output
The greatest loss is from the stomach in gastric juices (<1.5 mmol.kg 21 .day 21 ). There is a further loss from the gastrointestinal tract (<1 mmol.kg 21 .day 21 ) in the form of bile, pancreatic and intestinal secretions. Chloride is secreted into the intestinal lumen via channels regulated by protein kinases. One of these is activated by protein kinase A and therefore by cyclic adenosine monophosphate (cAMP). Some bacteria, notably Vibrio cholerae, produce a toxin that binds to the Gs protein, producing a marked increase in cAMP, leading to profuse secretory diarrhoea. Normally about 15 mmol.day 21 are lost in sweat.
In the renal tubule, chloride excretion varies with the need for bicarbonate. Chloride is excreted with ammonium ions to eliminate hydrogen ions in exchange for sodium. This occurs mainly in the proximal tubule and can result in the production of acid urine even in the presence of a metabolic alkalosis, as seen in pyloric stenosis. In the ascending limb of the loop of Henle, chloride is reabsorbed with sodium. Regulation of chloride is passively related to sodium and inversely related to plasma bicarbonate. Therefore, aldosterone indirectly influences chloride concentrations.
Chloride shifts
As erythrocytes move through the peripheral tissues, carbon dioxide is converted by the action of carbonic anhydrase to bicarbonate. About 70% of the bicarbonate produced will diffuse into the plasma and chloride shifts into the cell to maintain electrochemical neutrality. The reverse occurs when the blood reaches the lungs. These exchanges are known as chloride shifts. In respiratory disturbances, up to 30% of an acid load can be buffered by similar chloride2bicarbonate ionic shifts between the intracellular fluid (ICF) and extracellular fluid [2] . In chronic respiratory acidosis, a compensatory metabolic alkalosis occurs with a subsequent chloride shift from the erythrocyte to the plasma in exchange for bicarbonate. In respiratory alkalosis, hydrogen moves from the intracellular space to maintain electroneutrality, whereas excess bicarbonate moves into the erythrocyte in exchange for chloride. The causes of chloride flux are given in Table 1 .
Implications for fluid resuscitation and acid2base management. The choice of fluids containing chloride ranges from hypertonic, e.g. 1.8% NaCl, to hypotonic, e.g. 0.18% NaCl, in dextrose saline. These are normally chosen for their sodium content and osmolarity and therefore their effect on expanding the ECF. They are usually unbuffered and can have a profound effect on acid2base balance.
It is important to be aware that over-reliance on normal saline as a resuscitation or maintenance fluid will result in a hyperchloraemic acidosis [3±5] . This can have significant effects in the postoperative period [6] that may be ascribed erroneously to other pathology [7] . It can be corrected by the judicious use of sodium bicarbonate and is preferable to allowing hyponatraemia to develop perioperatively, as may occur with transurethral resection of the prostate (TURP syndrome). There may be an added benefit to using hypertonic saline as a`preload' before regional anaesthesia in such cases [8] .
Just as an excess of chloride can cause a metabolic acidosis, it is notable that metabolic alkalosis and hypokalaemia are the hallmarks of chloride depletion. The classic example is that of gastric outflow obstruction, in particular pyloric stenosis [9] . Metabolic alkalosis can be divided, for therapeutic purposes, into saline-resistant and saline-responsive types. Urinary chloride concentration can be helpful in determining the aetiology of the alkalosis provided no diuretic has been administered [1] . A urinary chloride of , 10 mmol.l 21 implies that the 21 suggests that a saline-resistant metabolic alkalosis is present. The latter is caused mainly by hyperadrenocorticism in which renal bicarbonate excretion is stimulated and these patients remain alkalotic despite chloride administration.
Fluoride
Fluorine has been known to decrease the boiling point, increase the stability and generally decrease the toxicity of anaesthetic vapours since 1932 [10] . Although it forms stable bonds, it was not until after World War II that advances in chemistry enabled the fluorination of organic compounds to become a reality.
The problem with fluorination became apparent soon after the introduction of methoxyflurane with the first report of nephrotoxicity [11] , followed shortly thereafter by the conclusive dose2response study by Cousins & Mazze [12] . An apparent renal threshold for nephrotoxicity was established at . 50 m mol.l 21 and went unchallenged for . 20 years. It was even extrapolated to other fluorinated volatile anaesthetics, a view that can no longer be supported [13, 14] . It was found to be more common in cases in which cytochrome P450 2EI induction had occurred [15, 16] or in which there was pre-existing renal disease [17] . The former was noted with chronic isoniazid therapy, obesity [18, 19] , untreated diabetes mellitus and alcohol abuse [16] . It has not proven to be a problem with children taking antiepileptic drugs [20] .
As explanations were sought, the original concept of MAC-hours gave way to that of the area under the fluoride concentration curve (AUC) [21] . Methoxyflurane has a much larger AUC than expected, given that the half-life of fluoride in blood is 90 min. It also has a much larger AUC than any other volatile agent, including sevoflurane. The difference was at first thought to be related to both the greater lipid solubility and the degree of metabolism of methoxyflurane. Sevoflurane undergoes considerable metabolism to fluoride ions (3±5%) but its lipid solubility is low and therefore its uptake by tissues much less. However, studies have shown that even after sevoflurane anaesthesia that produced fluoride ion concentrations . 50 m mol.l 21 for prolonged periods, nephrotoxicity did not occur [22±25] . Similarly, prolonged anaesthesia [26] or sedation on the intensive care unit (ICU) [27±30] with isoflurane did not produce clinically significant kidney damage. Enflurane, however, has been observed to cause decreased urine concentrating capacity at a fluoride concentration . 33.6 m mol.l 21 [31] . It was subsequently proposed that there may be additional or confounding factors in the aetiology of nephrotoxicity that include intrarenal formation of fluoride ions [32] , formation of other toxic compounds, e.g. hexafluoroisopropanol (HFIP) [33] , or changes in renal plasma flow. More recently, it has been observed that maximum fluoride concentrations do not exceed 20 mmol.l 21 in children undergoing sevoflurane anaesthesia and they are therefore unlikely to be at risk from renal toxicity [34, 35] . Despite some early misgivings [33] , sevoflurane is now well established as the agent of choice for inhalational induction in both adults and children.
It has been noted that at a urinary pH . 7.0 [36, 37] , mannitol, but not furosemide, increases fluoride excretion [38] , although this has not been put to specific therapeutic use. Fluoride also stimulates periosteal and endosteal bone formation, but as it replaces the hydroxyl ion in the hydroxyapatite lattice, there may be a consequent loss of strength and the potential for fracture. However, there have not been any reports of fluorosis after long-term exposure in operating theatre personnel outside the setting of drug abuse [39] .
Bromide
Locock introduced bromide in 1857 as a sedative anticonvulsant. Its inclusion lends stability to molecular structures, as exemplified by the non-depolarising neuromuscular blocking drug vecuronium bromide and the inhalational anaesthetic halothane. The metabolism of halothane leads to debromination and the bromide may reach psychoactive concentrations (480 m g.ml 2l ) after anaesthesia [40] . This has been observed in both adults [41±43] and children [44] . The extent of this debromination is not possible to predict [45] . The half-life of bromide is 12±14 days and its cumulative effects are an important consideration with repeat anaesthesia, e.g. for neuro-oncology treatments [44, 46] . Elevated concentrations have also been noted in anaesthetic [47] and operating theatre personnel [48] when measured using X-ray fluorescence spectrometry. However, psychoactive side-effects have not been demonstrated in these groups.
Debromination has not been shown to be a problem with neuromuscular blocking drugs, as the amounts used are much smaller. Halides in high concentrations have been shown to displace some basic drugs from albumin, but this has not been demonstrated with bromide up to concentrations of 4 mmol.l 21 [49] . 
The ratio of bicarbonate to carbonic acid is 20:1. Its pK value is 6.1 and at first glance one would expect the chemical buffering capacity at pH 7.4 to be poor. However, it is the quantity of bicarbonate in plasma (24±28 mmol.l
21
) that is significant. Furthermore, as blood becomes more acidotic, its pK value is approached and the efficiency of the buffer system increases. One of the most important features of the system is its responsiveness. In the short-term, changes in pH can be compensated for by adjustments of P a co 2 achieved via the lungs, and in the longer term by adjustments in plasma bicarbonate achieved via the kidneys. It is important to mimic this system and to increase the minute ventilation appropriately when managing patients with a metabolic acidosis. The ventilatory management of patients with metabolic alkalosis is more difficult, as a normal minute volume may reduce the patient's own compensatory hypercapnia and initially worsen the alkalosis. Ideally, ventilation should be avoided until the alkalosis has been reversed. If this is not possible, ventilatory strategies that allow P a co 2 to increase, i.e. permissive hypercapnia, should be considered. The main causes of changes in plasma bicarbonate concentration are listed in Table 2 .
Therapeutic uses of bicarbonate
Correction of metabolic acidosis
The first solutions of sodium bicarbonate (2.74%) were formulated at the Westminster Hospital. It was first used in an anaesthetic context in 1962 to treat the metabolic acidosis that was thought at the time to cause`neostigmine resistant curarisation' [50] . Hunter had earlier described this syndrome that caused high mortality in patients with long-standing intestinal obstruction. The therapy was a resounding success and marked a milestone in the evolution of the therapeutic uses of bicarbonate.
The amount of bicarbonate, in mmols, necessary to correct an acidosis can be calculated by the product of the treatable volume (0.3 Â body weight in kg) and the base deficit. This equates to the amount, in ml, of an 8.4% bicarbonate solution (1 mmol.ml 21 ). However, over treatment with bicarbonate can have many deleterious effects. It may not only cause an initial increase in P a co 2 , worsening intracellular acidosis, but it may also result in a rebound metabolic alkalosis after correction of the metabolic acidosis. Hypokalaemia may result from an intracellular shift of potassium. The sodium load may cause severe hypernatraemia and increased osmolarity [51] , which can result in fluid overload in patients with heart failure, or intracranial haemorrhage in neonates [52] and premature infants [53] . Bicarbonate can have adverse vasodilatory effects, especially under anaesthesia [54] , and it has been recommended that invasive monitoring be used to guide administration [55] . Bicarbonate is best avoided in diabetic ketoacidosis, as it can precipitate impaired oxygen delivery to the tissues by unmasking the unopposed action of 2,3-diphosphoglycerate (2,3-DPG) [56] . Bicarbonate administration causes a decrease in ionised calcium as a result of increased binding to albumin, and this may lead to tetany.
To avoid some of these complications, in particular the increase in P a co 2 , other buffers have been investigated, e.g. trihydroxymethylaminomethane (THAM), Carbicarb and Tribonat. All these agents are anions. Guidelines for the administration of THAM have been reviewed [57] . The main advantages are regeneration of bicarbonate with a lowering of P a co 2 , slow penetration of the intracellular space, maintenance of buffering power in hypothermia and effectiveness in a closed or semiclosed system. However, it has been associated with severe thrombophlebitis and tissue necrosis, alkalosis with hypoventilation and arterial vasodilatation, with a consequent decrease in coronary perfusion pressure. Tribonat is a mixture of THAM, sodium ........................................................................................................................................................................................................................................ [58] .
Emergency treatment of hyperkalaemia
Bicarbonate administration results in the intracellular redistribution of potassium ions. This may restore ECG morphology and occasionally lead to the return of the cardiac output after cardiac arrest [59] .
Decreasing latency of local anaesthetic blocks
There are numerous studies that show that the onset [60± 64] and duration of action [65, 66] of local anaesthetic blocks can be increased by alkalinisation of local anaesthetics. The proposed mechanism is that the alkaline pH promotes the local anaesthetic to remain in the unionised state, in which form it crosses the neural membrane. Others have suggested that the effect is limited to solutions containing epinephrine [67] , albeit in vitro.
Forced alkaline diuresis for removal of acidic drugs or toxins
Myoglobinuria is a feature of rhabdomyolysis and cast formation may cause acute renal failure. Myoglobin remains soluble if the urinary pH is kept . 6.5. Ron et al. first described a protocol for alkalinizing the urine with bicarbonate and maintaining a diuresis [68] . Forced alkaline diuresis has also been used as an adjunct in the treatment of overdosage with tricyclic antidepressants but is no longer recommended.
Phosphate
Phosphorus comprises < 1% of total body weight in the form of phosphate ion. It is the most abundant anion in the intracellular compartment. The majority (85%) is stored in bone as hydroxyapatite crystals, with the rest being stored in the soft tissues (14%) and blood (1%).
Approximately 1 g of phosphorus is ingested daily. This is well in excess of the dietary needs as only < 70% (700 mg) is absorbed, mainly through the small intestine. Phosphorus absorption from the intestine is remarkably efficient and hypophosphataemia secondary to deficient absorption is rare in the absence of antacids. There are both passive and active mechanisms, the latter being more active when dietary intake is low, with absorption approaching 90%. The kidneys normally excrete 700 mg.day 21 by filtering 6 g and reabsorbing 5.3 g, thus maintaining a balance between intake and output. Phosphorus absorption occurs under the influence of vitamin D, whereas phosphate excretion is primarily influenced by parathyroid hormone.
Phosphate exists in the body in both organic and inorganic forms. Most intracellular phosphate is organic, taking the form of adenosine triphosphate (ATP), nucleic acids, phospholipids and phosphoproteins. Extracellular phosphate exists mainly in the inorganic form. This is the freely diffusible form and is the fraction that is measured in plasma. In contrast to calcium, only 12% of phosphate is bound to albumin and is thus not affected by changes in serum albumin.
The functions of phosphate in the body have been outlined in a recent review [69] . The main function is to store and release energy via compounds such as ATP that contain high-energy phosphate bonds. Phosphate is an integral part of the structure of proteins, lipids and bone. It is an intracellular and renal tubular buffer with a pK a of 6.8. Phosphate achieves maximum buffering power when it is concentrated in the renal tubules where the pH is closer to its pK a , although the ammonium buffer system has a greater buffering capacity. It is the most important intracellular buffer and is essential for the intermediary metabolism of carbohydrate [70] . The activity of phosphofructokinase, the rate-limiting enzyme in glycolysis, is increased by alkalosis. This causes increased cellular uptake and hypophosphataemia. Therefore, over ventilation of patients' lungs during surgery may not only remove the stimulus to breathe (co 2 ) but may also potentially impair the ability to breathe.
Phosphate is a component of 2,3-DPG, which is crucial to tissue oxygen delivery [71] , and of the intracellular messengers, cAMP and cyclic guanosine monophosphate (cGMP). It is necessary for the optimal functioning of both the immune system and the coagulation cascade. The process of opsonisation and phagocytosis by leukocytes, and many of the steps in the coagulation cascade require ATP.
Regulation of phosphate in the ECF
The normal concentration of phosphate in the ECF is maintained between 0.8 and 1.0 mmol.l 21 by two mechanisms.
Overflow mechanism. Phosphate filtered through the glomerulus is normally reabsorbed through the proximal tubules. Renal tubules have a transport maximum of 0.1 mmol.min 21 and when more phosphate is presented, the excess is excreted and is normally < 10±15% of the filtered load. This reabsorption from the proximal tubule is dependent on parallel sodium absorption and therefore diuretics that act on this part of the nephron will cause phosphaturia.
Role of the parathyroid glands. The parathyroid glands, which have a major role in the regulation of calcium ions, can decrease phosphate ion concentration in two different ways. Parathyroid hormone decreases the transport maximum for phosphate in the renal tubules, thereby increasing the proportion of phosphate that is lost in the urine. It also promotes bone reabsorption with a loss of phosphate from the ECF.
Causes of hypophosphataemia [69, 72] 1 Decreased intake and/or absorption: malnutrition, aluminium antacids.
2 Increased urinary excretion: carbonic anhydrase inhibitors, diuretics, the osmotic effect of glycosuria, glucocorticoids.
3 Internal redistribution: alkalosis (metabolic and respiratory), total parenteral nutrition and catecholamine release which cause hyperglycaemia, resulting in an intracellular shift of phosphate.
4 Haemodilution: hypophosphataemia has long been recognised as a consequence of intravenous fluid therapy during surgery. However, as the 2,3-DPG concentration [71] and postoperative muscle function [73] are unaffected, it is of limited significance in fit patients with normal cellular stores and does not require treatment. However, established hypophosphataemia has been shown to cause respiratory muscle weakness in the general inpatient population [74] . It may even result in respiratory failure on its own [75, 76] or in combination with other causes [77, 78] , such as pneumonia. There is a need to recognise those subgroups of patients who are at risk from chronic phosphate deficiency [79] , as it is likely to contribute to postoperative hypoventilation. Patients with chronic obstructive airways disease may have phosphate depletion from a combination of malnutrition, steroid and diuretic use [80] . The severe alcoholic also suffers from malnutrition. In uncontrolled diabetes, phosphate excretion and redistribution are increased [76] and hypophosphataemia may be made worse by insulin administration.
The cardiovascular effects of hypophosphataemia include ventricular arrhythmias and, in chronic states, a reversible congestive cardiomyopathy. Erythrocyte and leukocyte dysfunction may ensue due to ATP depletion. Haemolytic anaemia may occur because of increased red cell fragility and 2,3-DPG depletion may result in impaired oxygen delivery. Neurological features may be pronounced, usually developing over 7±10 days after hyperalimentation or refeeding has commenced, and consist of agitation, confusion and hyperventilation that can progress to seizures, coma and death. Skeletal demineralisation occurs after chronic deficiency, especially where there is increased bone turnover and this may mimic osteomalacia. Metabolic acidosis occurs infrequently considering phosphate's renal buffering capacity and deficiency also impairs ammonium production. Carbonate ions are also released during demineralisation and buffer the hydrogen ions. Conditions in which hydroxyapatite cannot be mobilised, e.g. vitamin D deficiency and severe magnesium deficiency, may result in metabolic acidosis. Rhabdomyolysis is thought to occur only in patients with pre-existing myopathies such as that which occurs in chronic alcoholics.
Treatment of hypophosphataemia
The mainstay of treatment is supplementation or replacement. Hypophosphataemia has been shown to be a poor prognostic factor in patients requiring intensive care [81] . Although an increase in single indices such as the P 50 for oxygen dissociation have been demonstrated [82] , good studies showing an improved clinical outcome with phosphate therapy are, as yet, lacking. Various treatment protocols have been described. Vannatta et al. [83] concluded that it is safe to infuse 0.32 mmol.kg 21 Causes of hyperphosphataemia 1 Decreased renal excretion, increased intestinal reabsorption.
2 Exogenous sources: parenteral administration, poisoning [85] .
3 Release after cell damage. This has been shown to occur commonly after tumour lysis [86] but not after abdominal aneurysm repair [87] .
4 Internal redistribution: acidosis, reduced insulin concentration.
5 Spurious: thrombocytosis, hyperlipidaemia. No direct symptoms can be ascribed to hyperphosphataemia. It may cause arrhythmias, hypotension and hypocalcaemia with associated tetany, renal failure, and ectopic calcification if high concentrations are maintained for long periods.
Treatment of hyperphosphataemia
Hyperphosphataemia in concentrations of up to three times the normal are well tolerated in the short-term. Therapy should be directed at the cause wherever possible. This will involve the discontinuation of any exogenous sources of phosphate. Phosphate binding antacids given orally, e.g. aluminium hydroxide, may be used to decrease the amount absorbed from the gastrointestinal tract. An intracellular shift of phosphate can be achieved by the administration of hypertonic dextrose solutions while maintaining a normal pH. Ensuring adequate hydration will promote excretion by the kidneys. When cell death or tumour lysis is the cause of ........................................................................................................................................................................................................................................... 
Sulphate
The dietary requirements for sulphur are met by the breakdown of the amino acids methionine and cysteine. Sulphur is excreted as the inorganic anion, sulphate. The disulphide bond is crucial to the three-dimensional structure and hence the function of proteins. Sulphate readily forms conjugates with drugs and protein structures. It is a major biotransformation pathway for phenolic drugs in humans, particularly in neonates [88] . Propofol, for example, has both glucuronidated and sulphated conjugates, e.g. 4-quinol sulphate. This pathway is a saturatable system and it is thought that the depletion of inorganic sulphate by exogenous substances can affect the metabolism of neurotransmitters [88] . It can combine with haemoglobin to form sulph-haemoglobin, and cyanosis will occur if the concentration exceeds 0.5 g.dl 21 [89] . The latter is more likely with the breakdown of phenacetin and sulphonamides that have numerous sulphur atoms in their structure. Sulphates may also form conjugates with polysaccharides and proteoglycans on cell surfaces. These have been postulated to form the trigger for anaphylaxis [90] . Sulphates may accumulate up to 10-fold during renal failure and may cause a metabolic acidosis with an increased anion gap that responds readily to haemodialysis [91] . It has also been suggested that sulphates may play a role in the osteodystrophy of renal failure [92] .
Anion gap
The principle of electroneutrality requires that the total positive electrical charge in body fluids equals the total negative electrical charge [93] . However, clinical laboratories only measure the most common electrolyte profiles, i.e. sodium, potassium, chloride and bicarbonate. This results in an apparent imbalance on the anion side of the equation that is known as the anion gap.
Anion gap Na
The normal mean (SD) anion gap is 12 (4) mmol.l
21
, although newer methods of assaying chloride have in some series led to a lower range, and it is best to be guided by the local laboratory. The factors that may increase or decrease the anion gap are summarised in Table 3 .
Albumin is strongly polyanionic at physiological pH and is largely responsible for the magnitude of the anion gap. Therefore, changes in its concentration and dissociation will lead to a corresponding change in the anion gap. Gabow et al. [94] proposed that the anion gap is decreased by a factor of 2.5 mmol.l 21 for every 1 g.dl 21 decrease in albumin, and this has been validated scientifically [95] . However, it has not yet been shown that hypoalbuminaemia can mask a significant anion gap acidosis [96] . As sodium is the largest portion of the measured cations, changes in its concentration can have a profound effect on the anion gap. Cations that are not included in the equation, such as magnesium and calcium, normally do not have an effect on the anion gap unless the disturbance in their concentration is severe. Halide salts can cause interference with most chloride assays, giving falsely high values.
Significance of the anion gap
An increased anion gap in a patient is a poor prognostic indicator [97] and should prompt consideration of intensive care or high-dependency care. The anion gap may also help diagnose the cause of a metabolic acidosis. To counter an effective decrease in bicarbonate, there must be a corresponding increase in another anion or a decrease in cation concentration. If the anion gap and the cation concentrations remain normal, the balancing anion must be chloride, as this is the only other anion that is ............................................................................................................................................................................................................................................. measured, and the cause of the acidosis is likely to be hyperchloraemia [3, 98] .
However, if the anion gap is increased, then the balancing anion must be one that is unmeasured. If urea, glucose and electrolyte measurements are normal, increased anions from renal failure, e.g. phosphate or sulphate, or diabetes (3-hydroxybutyrate) are unlikely. Other osmotically active substances must be present and it is worth noting from the outset that if the anion gap is . 25 mmol.l 21 , an organic cause is likely [94] . A lactate level can be easily measured in most hospitals and a toxicology screen normally excludes the more common poisons such as alcohol and salicylates. If there is a high index of suspicion for abuse of substances such as methanol or ethylene glycol, then it is worth calculating the osmolal gap (calculated 2 measured osmolalities). Early treatment on this basis before poison levels were available has been shown to be highly effective [99, 100] .
The anion gap can also be useful in distinguishing the primary imbalance in mixed acid2base disorders. The simplest example is that of diabetic ketoacidosis with alkalaemia [101] . In this condition, the metabolic acidosis caused by the ketone bodies is countered by the metabolic alkalosis caused by persistent vomiting. Arterial blood gases may not be helpful if both conditions are of equal severity. An increased anion gap demonstrates the underlying aetiology.
Limitations of the anion gap
It is important to be aware of the limitations [102] and pitfalls in interpretation [96] of the anion gap.
1 Insensitivity: it has been found that the anion gap is relatively poor at identifying small changes in ion concentrations, especially lactate [103] , even when they would be considered clinically significant.
2 Competing factors: if two clinical conditions known to cause opposing effects on the anion gap were to coexist, the diagnostic usefulness of the anion gap may be diminished.
3 Slow onset metabolic acidosis: when a metabolic acidosis is of sufficiently slow onset and renal function remains normal, the patient may be able to excrete enough anions so that the anion gap remains normal. This may explain why some cases of diabetic ketoacidosis may present with a normal anion gap [104] .
4 Mixed acidosis: occasionally, a metabolic acidosis can be caused by a combination of conditions that have opposing effects on the anion gap, potentially masking one another. It is possible to resolve this diagnostic conundrum through the calculation of the change in the anion gap divided by the change in the bicarbonate concentration (DGap/DHCO 3 2 ) [105] . However, it assumes that each mmol of acid will decrease the serum bicarbonate by a similar amount, but this will only hold true when the proton and its conjugate base have the same volume of distribution. This is certainly not the case in lactic acidosis (lactate has a smaller volume of distribution than the protons) or severe acidosis [96, 106] .
5 Unidentifiable anions: it has been found in some series that the offending anion contributing to the anion gap cannot be identified despite special effort [94] .
6 Laboratory error: an error in the measurement of any of the cations or anions in the equation will be translated into an error in the anion gap.
Strong ion difference
The limitations of the anion gap have led some researchers to adopt a physicochemical approach using the strong ion difference or gap (SID) [107] . This approach takes into account not only the principle of electroneutrality but also the law of conservation of mass. In order to understand the body's defence of pH, it is necessary to understand the regulation of three independent variables: SID, Pco 2 and A TOT (total weak acid concentration) [108] . The advantage of this approach is that it takes account of the smaller cation concentrations, plasma albumin and phosphate concentrations. It helps explain`dilutional acidosis' and how hyperlactataemia can exist without acidaemia. It is also more helpful than the anion gap in establishing the presence of unidentified anions in the critically ill and in mixed acid2base disorders [109] . It has been explored in both adult and paediatric intensive care settings [110, 111] . However, it has not been introduced without controversy and as yet has not received wide acceptance [112, 113] . It does provide a different perspective on acid2base balance and merits further study and debate.
Organic anions
The commonest organic anions in the body are albumin and lactate and their physiological importance is discussed here for completeness.
Albumin
Albumin is a medium-sized plasma protein with a molecular mass of 69 000 Da. It is a polyvalent anion and can readily accept further negative charge. Its effect on the anion gap has already been discussed. The normal half-life of albumin in plasma is between 18 and 20 days, but this is not the case with exogenously administered albumin, which has a shorter half-life. Although it is a medium-sized molecule, it has a transcapillary escape rate (TER) of 5%.h 21 . Ninety per cent of the extravascular albumin returns to the circulation and the other 10% undergoes catabolism. ........................................................................................................................................................................................................................................... Albumin has a fundamental role in the transport of hormones and ions, and forms a reservoir or buffer preventing wide variations in serum concentrations. Competition between drugs does occur and is increased during hypoalbuminaemia. The effects are more marked for drugs that are highly protein bound, such as propofol, than for midazolam or thiopental.
Albumin is thought to be responsible for 75±80% of the colloid osmotic pressure of human plasma. It was considered that measures to maintain colloid osmotic pressure in the critically ill could make a difference in outcome. However, a systematic review [114] reported an increase in mortality in critically ill patients who had received albumin. This sparked a vigorous debate with the methodology in the study being severely criticised [115± 117] . Two recent reviews by Boldt [118] and Nicholson [119] dealt with this vexed issue and are strongly recommended to the reader.
Albumin is a scavenger of free radicals. It also exhibits anticoagulant effects in its own right by inhibiting platelet aggregation and enhancing the inhibition of factor Xa by antithrombin III. Despite its multiple functions, it is not crucial for life, as cases of analbuminaemia occur rarely. These patients display only moderate oedema and are able to handle drugs. It is thought that other plasma proteins increase and take on the role of albumin [120] .
Lactate
Lactic acidosis is one of the commonest causes of metabolic acidosis in medical practice. Lactic acid is a weak acid (pK a 3.8) and is therefore almost completely dissociated at physiological pH. Lactate is a carbohydrate anion and the normal concentration in blood is 1±2 mmol.l
21
. Lactate may be produced or consumed by all cells, but skeletal muscle, the gut, the brain and erythrocytes are the main producers (10±20 mmol.kg 21 .day 21 in adults). Lactate is an intermediary in carbohydrate metabolism. Glucose is catabolised in a series of steps to pyruvate by the Embden-Meyerhof pathway. Pyruvate in non-gluconeogenic organs has four potential fates: conversion to acetyl coenzyme A by pyruvate dehydrogenase; transamination by alanine aminotransferase with glutamate to alanine and a-ketoglutarate; carboxylation to oxaloacetate or malate; reduction by nicotinamide adenine dinucleotide (NAD)H to lactate and NAD 1 catalysed by lactate dehydrogenase. Lactate can be used as a source of energy but the process is very inefficient and it is normally transported from the peripheral tissues back to the liver (Cori cycle) where it is removed from the blood by gluconeogenesis. Up to 70% of lactate is metabolised in this way. The other 30% is metabolised by oxidation in the liver and kidneys.
Lactate concentration in the cell is regulated by the pyruvate concentration, the redox state of the cell and hydrogen ion concentration in the cytosol. One step in the Embden-Meyerhof pathway is essentially irreversible and is catalysed by phosphofructokinase. In metabolic acidosis, this enzyme is inhibited and lactate production is decreased, whereas in metabolic alkalosis, phosphofructokinase is stimulated and lactate production is increased.
Causes of lactic acidosis;
Lactic acidosis was originally classified into two categories, Type A and Type B. In Type A lactic acidosis, there is an imbalance between oxygen supply and demand, and lactate is generated by anaerobic metabolism. In Type B lactic ............................................................................................................................................................................................................................................. acidosis, tissue hypoxia is irrelevant and abnormalities in pyruvate metabolism are probably the cause. The causes of lactic acidosis are listed in Table 4 .
Significance of lactic acidosis
Although lactate per se is not detrimental and high levels are found during severe exercise in healthy adults, it is associated with a poor prognosis in critically ill patients [121] . It is the trend rather than any single measurement that is associated with a high mortality [122] . However, therapies that have been aimed directly at lowering serum lactate have failed to produce a significant impact on this mortality rate [123] . Lactate has been cited as a marker of tissue hypoxia for over 30 years [124] . This is now being questioned because it is recognised that there are multiple mechanisms through which it may increase in the critically ill [125±127]. It is thought that it is the inability of non-survivors to increase oxygen consumption that is at fault [128] , and lactate remains high in this group as a result. The exact origin of lactic acidosis, in particular the anatomical site of lactate production in sepsis, has yet to be elucidated. The lung is thought to be a significant producer of lactate in acute lung injury [129] .
It has been shown that the understanding of the purpose and metabolism of lactate in Hartmann's solution is lacking [130] . It was first added to an intravenous fluid preparation because it was non-irritant and acted as a source of bicarbonate and glucose after lactate metabolism. Therefore, it would be prudent to restrict the volume of Hartmann's solution used in the fluid management of both septic and diabetic patients.
It is reassuring to note that anaesthesia does not affect serum lactate despite the associated haemodynamic effects, presumably because an adequate oxygen supply is maintained throughout. This is the case for both general [131] and regional anaesthesia [132] .
Treatment of lactic acidosis
Although in patients with serum lactate concentrations . 5 mmol.l 21 , mortality exceeds 51% at 3 days after ICU admission [121] , therapy that successfully addresses the cause can result in a successful outcome despite the absolute lactate level. The acute increases in serum lactate that are seen peri-operatively, after major vascular surgery or when tourniquets are used, do not result in increased mortality, as the aetiology is usually self-limiting [133] . Oxygen delivery must be optimised, which may require artificial ventilation, measurement of cardiac index and the rational use of inotropes. Aiming for supranormal haemodynamic targets has not always been successful in changing outcomes [128] .
The use of bicarbonate has not been shown to influence outcome in septic patients despite improvements in pH. Its use cannot be recommended at present [126] , although it is necessary as the buffer in lactate-free haemodialysate. Some success has been reported in the treatment of combined renal failure and lactic acidosis with the use of continuous haemofiltration using lactate free dialysate [134] . This treatment does not mask lactate overproduction [135] and, in the face of sustained hyperlactataemia, an underlying diagnosis of fulminant hepatic failure or gangrenous bowel should be considered.
Dichloroacetate stimulates pyruvate dehydrogenase, thereby reducing lactate with an increase in bicarbonate. It has been studied extensively but its use does not decrease mortality and has not found much support [121] .
Anions and ion channel receptors
The reversible nature of electrostatic bonds is central to the proper functioning of ion channels whereby they are able to mediate fast transmission throughout the central nervous system (CNS). The intracellular influx of cations into nervous tissue causes depolarisation and excitation, whereas anions cause hyperpolarisation and inhibition. Anions may be either the activating ligands, e.g. gammaaminobutyric acid (GABA) and glutamate, or the ions that pass through the channels, e.g. chloride and bicarbonate.
Gamma-aminobutyric acid is the principal fast inhibitory neurotransmitter in the CNS. It acts on the GABA receptor that belongs to a family of ligand-gated ion channels that include the acetylcholine receptor, glycine and 5HT 3 receptors. There are three recognised receptor subtypes, GABA-A, GABA-B and GABA-C. It is the GABA-A receptor subtype that is pivotal to the action of anaesthetic, anxiolytic and anticonvulsant drugs. The structure of the GABA-A receptor is reviewed regularly as more is learned about its diversity [136±138] .
Activation of the GABA-A receptor increases the chloride conductance of the neuron. This chloride influx hyperpolarises the neuron and prevents an excitatory postsynaptic potential from being transmitted. The action of GABA can be enhanced by any of the following: potentiating the binding of GABA to its own receptor; increasing the frequency and/or duration of opening of the ionophore; acting directly on the channel itself in high concentrations. Barbiturates and neuro-active steroids [139] have been shown to act via all three mechanisms. Benzodiazepines, in contrast, increase the frequency of channel opening but do not act directly on it. Their enhancement of the affinity of GABA for its receptor is also limited and their clinical effects are dependent on receptor occupancy. Propofol increases GABA receptor binding in a concentration-dependent manner and acts synergistically with benzodiazepines [140] . This, combined with absence of reversal with flumazenil [141] , suggests that propofol acts at a separate site. Volatile anaesthetic agents also have been shown to act through GABA potentiation, again at different sites from intravenous agents [142, 143] . Evidence is increasingly in favour of there being a protein site of action for general anaesthetics [144] .
There are three major subtypes of glutamate receptors: N-methyl d-aspartate (NMDA), dl a-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) and kainate. The NMDA receptor is of particular importance for anaesthetists because it is the known site of action of ketamine [145] . It is involved in long-term potentiation that is widely regarded as an experimental analogue for the mechanism of learning and memory in the brain [146] . This has implications for the control not only of chronic pain syndromes [147] , such as phantom limb pain [148] , but also for preventing awareness during surgery under general anaesthesia. The associated calcium influx is thought to be the principal mediator of neuronal cell death during anoxia or stroke [149] . This has led to the development of specific antagonists such as dizocilpine (MK-801), with the aim of neuroprotection.
Conclusions
Anions play many important physiological and pharmacological roles that are of interest to the anaesthetist. Their ability to accept a proton makes them the logical choice for buffer systems, e.g. bicarbonate, urate, glutamate and phosphate. They provide the power behind cellular functions (phosphate). They are also involved in gas exchange (bicarbonate) and transport functions, e.g. glucose2lactate and albumin. The halogen group is responsible for making the working environment safer by decreasing the explosive risk of volatile agents. Because of the reversible and surmountable nature of the ionic bond, they are the perfect choice for the receptor±agonist interactions that are now thought to underpin the cellular mechanisms of anaesthesia.
